Allison Bratzel
Stock Analyst at Piper Sandler
(5)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARGX argenx | Maintains: Overweight | 750 820 | 756.38 | 8.41% | 14 | Aug 26, 2025 | |
IONS Ionis Pharmaceutical... | Maintains: Overweight | 62 65 | 63.16 | 2.91% | 2 | Aug 22, 2025 | |
ABVX Abivax | Maintains: Overweight | 70 112 | 84.01 | 33.32% | 1 | Jul 29, 2025 | |
REPL Replimune Group | Maintains: Overweight | 14 22 | 5.73 | 283.94% | 2 | Jun 2, 2025 | |
TYRA Tyra Biosciences | Assumes: Overweight | 33 | 12.52 | 163.58% | 1 | May 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 115 | 30.31 | 279.41% | 1 | Mar 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 4 6 | 2.95 | 103.39% | 1 | Mar 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 23 | 4 | 475% | 1 | Mar 11, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 26 | 5.71 | 355.34% | 1 | Feb 18, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 22 | 23.47 | -6.26% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 23 | 37.96 | -39.41% | 2 | Nov 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 28 42 | 31.67 | 32.62% | 3 | Oct 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 22 | 14.08 | 56.25% | 2 | Jul 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 4 | 1.47 | 172.11% | 2 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 8 20 | 5.39 | 271.06% | 4 | Mar 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 20 | 4.47 | 347.43% | 1 | Oct 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 25 | 16.87 | 48.19% | 1 | Apr 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 100 | 83.1 | 20.34% | 2 | Feb 8, 2023 |